ASTER DM HEALTHCARE share price has plunged 2% and is presently trading at Rs 355.2.
Meanwhile, the BSE HEALTHCARE index is at 36,843.2 (up 0.4%).
Among the top losers in the BSE HEALTHCARE index today are Dr. Reddys (down 0.4%) and SUN PHARMA ADV. RES. (down 0.4%).
KIMS (up 3.8%) and DR. LAL PATHLABS (up 1.9%) are among the top gainers today.
Over the last one year, ASTER DM HEALTHCARE has moved up from Rs 287.7 to Rs 355.2, registering a gain of Rs 67.5 (up 23.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,114.1 to 36,843.2, registering a gain of 46.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Natco Pharma (up 93.0%), Cadila Healthcare (up 92.8%) and Glenmark Pharma (up 90.7%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 77,496.4 (up 0.2%).
The top gainers among the BSE Sensex today are HDFC Bank (up 1.0%) and Ultratech Cement (up 0.9%). The most traded stocks in the BSE Sensex are ICICI Bank and HDFC Bank.
In the meantime, NSE Nifty is at 23,589.9 (up 0.2%). Ultratech Cement and Hindalco are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,523.2 to 77,496.4, registering a gain of 13,973.3 points (up 22.0%).
ASTER DM HEALTHCARE net profit fell 16.2% YoY to Rs 446 million for the quarter ended March 2024, compared to a profit of Rs 532 million a year ago. Net sales rose 20.7% to Rs 9,736 million during the period as against Rs 8,069 million in January-March 2023.
For the year ended March 2023, ASTER DM HEALTHCARE reported 20.9% decrease in net profit to Rs 4,755 million compared to net profit of Rs 6,011 million during FY22. Revenue of the company grew 16.4% to Rs 119,329 million during FY23.
The current Price to earnings ratio of ASTER DM HEALTHCARE, based on rolling 12 month earnings, stands at 63.0.
Equitymaster requests your view! Post a comment on "ASTER DM HEALTHCARE Plunges 2%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!